Sponge Cytology-Sampling Device Promising for Barrett’s Esophagus Dx
Swallowable sampling device combined with methylation biomarker panel IDs Barrett esophagus.
Swallowable sampling device combined with methylation biomarker panel IDs Barrett esophagus.
Over time, the prevalence of gastroschisis has increased, with more babies born with gastroschisis in areas with high and medium vs low opioid prescription rates, according to new research.
The gel breaks down immediately in the stomach so it does not affect the absorption rate of the medication, unlike other carriers that are used to facilitate swallowing.
Currently, there is no FDA-approved treatment for biliary atresia, a rare pediatric liver disease.
Men with inflammatory bowel disease (IBD) have an increased risk for prostate cancer (PCa), according to a study published online December 4 in European Urology.
CT-P13, which is a biosimilar of the reference product (RP) infliximab, has equivalent effectiveness for infliximab-naive patients with Crohn’s disease, according to a new study.
A total of 354 participants were randomly assigned to individual hypnotherapy, group hypnotherapy, and educational supportive therapy; after excluding ineligible participants, 142, 146, and 54 participants, respectively.
Data were included from 114 patients who completed the IBD-DI-SR validation phase; 63 and 51 had Crohn’s disease and ulcerative colitis, respectively.
HT-1 is a rare genetic disease that can cause hepatic, renal and peripheral nerve damage.
Psoriasis appears to be significantly associated with inflammatory bowel disease, according to a new review.